American Society of Gene + Cell Therapy
@asgct.bsky.social
910 followers 33 following 79 posts
Advancing knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
Posts Media Videos Starter Packs
asgct.bsky.social
📢 AVAILABLE NOW: Advancing CGTs for Cancer abstracts!

Explore the latest research from leading scientists + clinicians working to advance #CGT for cancer. Download 40+ pieces of original research on our website and register to join us in Philly! https://bit.ly/4nVlxIm
Advancing Cell + Gene Therapies for Cancer
Join us for Advancing Cell + Gene Therapy for Cancer this October to move beyond conventional science and explore the strategies, breakthroughs, and…
bit.ly
asgct.bsky.social
Key #PS25 takeaway from CMC session: Harmonization efforts are especially critical for bespoke “n of 1” therapies, ensuring patients can access treatment without unnecessary delays. #ASGCTAdvocacy
asgct.bsky.social
That’s a wrap on #PS25! Thank you to our speakers, attendees, + sponsors for an outstanding event! #ASGCTAdvocacy

We want to hear your feedback! Let us know how we did by filling out this short evaluation: https://bit.ly/46mRYd0
Dr. Snehal Naik Participants network at the 2025 ASGCT Policy Summit. Panelists discuss critical CGT challenges at the 2025 ASGCT Policy Summit. Panelists discuss critical CGT challenges at the 2025 ASGCT Policy Summit.
asgct.bsky.social
Welcome back to Day 2 of #PS25! This morning, we're kicking off with experts from @LifeEditTx, @Dyno_Tx, and @darkhorsecagt who will tell us how #AI is transforming #CGT discovery, trial design, and regulation. #ASGCTadvocacy
asgct.bsky.social
Carolyn Hutter of @genome_gov and Allison Bradbury at @nationwidekids dive into @NIH’s role to advance genomic medicine and patient-focused research. #ASGCTadvocacy #PS25
asgct.bsky.social
Live at #PS25: Melissa Majerol of CMMI digs into the CGT Access Model and how the federal value-based arrangement pilot is helping drive broader patient access. #ASGCTadvocacy
asgct.bsky.social
What does it take to onboard newly approved CGTs in hospitals? And where does LTFU come in as both a regulatory and patient experience issue? Speakers discussing real-world bottlenecks to clinical care at #PS25. #ASGCTadvocacy
asgct.bsky.social
Michelle McClure (@ACMG) and Dylan Simon (@EveryLifeOrg) are talking all things newborn screening at #PS25: where the system stands today, efforts to update and strengthen the system, and why patient advocates are at the heart of it all. #ASGCTadvocacy
asgct.bsky.social
#PS25 update: Experts are discussing EU HTA scientific advice for CGTs. Takeaway - early engagement with HTA bodies is critical for access strategies. #ASGCTadvocacy
asgct.bsky.social
Dr. Mimi Lee presents @ARPA_H’s multi-ecosystem collaboration for precision medicine. Exciting examples of cross-sector innovation in #raredisease #CGT development! #ASGCTAdvocacy #PS25
asgct.bsky.social
We’re live! Kicking off the 2025 Policy Summit with opening remarks from Dr. Snehal Naik, ASGCT Regulatory Affairs Committee Chair. Stay tuned for critical policy discussions shaping the #CGT landscape. #ASGCTadvocacy #PS25
asgct.bsky.social
✨ The Policy Summit (#PS25) STARTS TOMORROW in Washington, D.C.!

Dr. Snehal Naik, Chair of ASGCT's Regulatory Affairs Committee, shares why this event is important to the #CGT field. REGISTER NOW: https://bit.ly/3IyraNR

#ASGCTadvocacy
asgct.bsky.social
🚨 THIS FRIDAY IN DC: Dr. Katherine Szarama from the Office of the Director for @FDA's CBER will participate in a fireside chat at ASGCT’s Policy Summit (#PS25)!

This event is in person only; register to secure your spot: https://bit.ly/3KaYScC
ICYMI: Dr. Katherine Szarama from the Office of the Director for FDA's CBER will participate in a fireside chat at ASGCT’s Policy Summit (#PS25)!
asgct.bsky.social
💡 "I strongly believe we are in a moment," says @arpa-h.bsky.social's Dr. Mimi Lee, who is speaking at the 8th Annual Policy Summit NEXT WEEK in Washington, D.C.!

Hear why she's excited to attend this event and make sure to register: https://bit.ly/3KaYScC #ASGCTadvocacy #rarediseases
asgct.bsky.social
ASGCT appreciates Senate appropriators for their bipartisan leadership in advancing #CGTs. The $400M NIH increase and strong CGT support in the FY26 Labor-HHS bill reflect a shared commitment to transforming patient care through innovative science. #ASGCTadvocacy
asgct.bsky.social
Not your typical cancer conference.
Early reg for Advancing Cell + Gene Therapies for Cancer ends TONIGHT (11:59 pm CT)!
💡 Lowest rates
📺 On-demand access if you can’t join in Philly, the home of CAR-T
👉 Secure your spot now: https://bit.ly/4mJEbCH
asgct.bsky.social
⚡ BREAKING: New #NewbornScreening session added to Policy Summit!
Hear how ASGCT advances gene therapy access for all patients.
🎧 Podcast: https://newbornscreeningspotlight.podbean.com/e/american-society-of-gene-and-cell-therapy/
📍 Register: https://bit.ly/4o4es9k
#ASGCTadvocacy #PolicySummit
asgct.bsky.social
💡 Why attend the ASGCT Policy Summit in two weeks?

"You will be armed with new insights about how to ensure you are starting with the end in mind from even the earliest stages of discovery and development," says Dr. Emily Walsh Martin. #ASGCTadvocacy https://bit.ly/4niZ8Vc
At the 2025 Policy Summit, "you will be armed with new insights about how to ensure you are starting with the end in mind from even the earliest stages of discovery and development," says ASGCT Member Emily Walsh Martin.
asgct.bsky.social
🏆 It's the FINAL WEEK to nominate a colleague (or yourself!) for an Honorific Award!

Know someone who has made a significant impact on #CGT? Send your nomination to [email protected] through Sept. 16! Recipients present their work at #ASGCT2026! https://bit.ly/48am9VX
asgct.bsky.social
Submit your research through Sept. 30 to a special issue of @moltherapy.bsky.social Oncology (#MTO) on the history, current state, and future of advancements in pediatric cancer therapy!

Learn more + submit: https://bit.ly/4lYT5nC
Submit your research through Sept. 30 to a special issue of #MolecularTherapy Oncology (#MTO) on the history, current state, and future of advancements in pediatric cancer therapy!
Reposted by American Society of Gene + Cell Therapy
moltherapy.bsky.social
Out now: the September 2025 issue of Molecular Therapy features new research on in vivo base editing, stem cell therapy, microglial replacement, and more. Read the new issue today: www.cell.com/molecular-th...
New issue of Molecular Therapy out now!
asgct.bsky.social
🧬 NEXT MONTH: Join us in Philadelphia or on demand for Advancing Cell +Gene Therapies for Cancer! Immerse yourself in the latest science, discuss challenges, + forge collaborations with cancer experts.

Secure the lowest rates through Sept. 15! https://bit.ly/4mG8rP3
NEXT MONTH: Join us in Philadelphia or on demand for Advancing Cell +Gene Therapies for Cancer!
asgct.bsky.social
🔜 Join us at #NORDSummit Oct. 19–21!

This annual gathering from the National Organization for Rare Disorders unites patients, advocates, researchers, industry leaders, + policymakers committed to advancing #raredisease research and orphan product development. Register: https://bit.ly/3hsFO7E
Join us at #NORDSummit Oct. 19–21!
asgct.bsky.social
🚨 TONIGHT at 11:59 p.m. ET is the deadline to submit your #cancerresearch for possible presentation this fall at our Advancing Cell + Gene Therapies for Cancer conference!

Submit your work and we hope to see you in Philadelphia in October. https://bit.ly/479cAX5
TONIGHT at 11:59 p.m. ET is the deadline to submit your #cancerresearch for possible presentation this fall at our Advancing Cell + Gene Therapies for Cancer conference!